EP3283527
SAMSETT MEÐFERÐ VIÐ KRABBAMEINI
:
EP einkaleyfi í gildi á Íslandi:
12.4.2016:
13.1.2021:
16718802.8
:
1.3.2021:
15.3.2021
:
11.4.2036:
11.4.2025:
30.4.2025
:
COMBINATION THERAPY FOR CANCER
12.4.2016
13.1.2021
1.3.2021
15.3.2021
11.4.2025
:
Five Prime Therapeutics, Inc.:
111 Oyster Point Boulevard, South San Francisco, CA 94080, US
:
MASTELLER, Emma:
South San Francisco, California 94080, US
:
BRENNAN, Thomas:
South San Francisco, California 94080, US
:
BELLOVIN, David:
South San Francisco, California 94080, US
:
BAKER, Kevin:
South San Francisco, California 94080, US
:
WONG, Brian:
South San Francisco, California 94080, US
:
G.H. Sigurgeirsson ehf.:
Borgartúni 26, 105, Reykjavík,
:
201562146766 P:
13.4.2015:
US
:
201562190945 P:
10.7.2015:
US
:
US2016027038:
12.4.2016
:
C07K 16/28, A61K 39/395, A61P 35/00
: 6
: 15.2.2021
: 11.4.2022
: G.H. Sigurgeirsson ehf.
: 7
: 10.3.2022
: 11.4.2023
: Árnason Faktor ehf.
: 8
: 8.3.2023
: 11.4.2024
: Árnason Faktor ehf.
: 9
: 7.3.2024
: 11.4.2025
: Árnason Faktor ehf.